Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease

  • Jeffry S. Nyman
  • , Alyssa R. Merkel
  • , Sasidhar Uppuganti
  • , Bijaya Nayak
  • , Barbara Rowland
  • , Alexander J. Makowski
  • , Babatunde O. Oyajobi
  • , Julie A. Sterling

Producción científica: Articlerevisión exhaustiva

44 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease'. En conjunto forman una huella única.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology